Literature DB >> 25850692

Regulatory T cells: Mechanisms of suppression and impairment in autoimmune liver disease.

Rodrigo Liberal1, Charlotte R Grant, Maria Serena Longhi, Giorgina Mieli-Vergani, Diego Vergani.   

Abstract

There are three classic liver diseases with probable autoimmune etiology: primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis. The occurrence of these autoimmune conditions is determined by the breakdown of immune-regulatory mechanisms that in health are responsible for maintaining immunological tolerance against self-antigens. Among the multiple T cell subsets with suppressive function, the regulatory T cells (Tregs), defined by the expression of CD4, the IL-2 receptor α chain (CD25), and the transcription factor FOXP3, have emerged as having a central role in maintaining immune-tolerance to autoantigens. Tregs are equipped with an array of mechanisms of suppression, including the modulation of antigen presenting cell maturation and function, the killing of target cells, the disruption of metabolic pathways, and the production of anti-inflammatory cytokines. In all the three autoimmune liver diseases mentioned above, there is evidence pointing for either a reduced frequency and/or function of Tregs. Here, we review the definition, phenotypic characteristics, and mechanisms of suppression employed by Tregs and then we discuss the evidence available pointing to their impairment in patients with autoimmune liver disease.
© 2015 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  autoimmune hepatitis; mechanisms of suppression; primary biliary cirrhosis; primary sclerosing cholangitis; regulatory T cells

Mesh:

Substances:

Year:  2015        PMID: 25850692     DOI: 10.1002/iub.1349

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  22 in total

Review 1.  The role of FOXP3+ regulatory T cells in human autoimmune and inflammatory diseases.

Authors:  A Mohr; M Atif; R Balderas; G Gorochov; M Miyara
Journal:  Clin Exp Immunol       Date:  2019-03-24       Impact factor: 4.330

2.  Liver tissue metabolically transformed by alcohol induces immune recognition of liver self-proteins but not in vivo inflammation.

Authors:  Michael J Duryee; Benjamin M Wiese; Jordan R Bowman; Jared D Vanlandingham; Lynell W Klassen; Geoffrey E Thiele; Carlos D Hunter; Daniel R Anderson; Ted R Mikuls; Geoffrey M Thiele
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-12-28       Impact factor: 4.052

3.  Gene-disease associations identify a connectome with shared molecular pathways in human cholangiopathies.

Authors:  Zhenhua Luo; Anil G Jegga; Jorge A Bezerra
Journal:  Hepatology       Date:  2018-01-02       Impact factor: 17.425

Review 4.  Exploring the Pathogenic Role and Therapeutic Implications of Interleukin 2 in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2020-08-24       Impact factor: 3.199

5.  Elevation of Vδ1 T cells in peripheral blood and livers of patients with primary biliary cholangitis.

Authors:  F Hua; L Wang; X Rong; Y Hu; J M Zhang; W He; F C Zhang
Journal:  Clin Exp Immunol       Date:  2016-09-09       Impact factor: 4.330

6.  Regulatory T cells promote alloengraftment in a model of late-gestation in utero hematopoietic cell transplantation.

Authors:  John S Riley; Lauren E McClain; John D Stratigis; Barbara E Coons; Nicholas J Ahn; Haiying Li; Stavros P Loukogeorgakis; Camila G Fachin; Andre I B S Dias; Alan W Flake; William H Peranteau
Journal:  Blood Adv       Date:  2020-03-24

7.  A kinetic model of T cell autoreactivity in autoimmune diseases.

Authors:  M P Machado Ramos; C Ribeiro; A J Soares
Journal:  J Math Biol       Date:  2019-09-09       Impact factor: 2.259

Review 8.  Evolving Role of Vitamin D in Immune-Mediated Disease and Its Implications in Autoimmune Hepatitis.

Authors:  Albert J Czaja; Aldo J Montano-Loza
Journal:  Dig Dis Sci       Date:  2018-10-28       Impact factor: 3.199

Review 9.  Immune Inhibitory Properties and Therapeutic Prospects of Transforming Growth Factor-Beta and Interleukin 10 in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2021-04-09       Impact factor: 3.199

10.  Activation of AMPKα1 is essential for regulatory T cell function and autoimmune liver disease prevention.

Authors:  Huaiping Zhu; Zhaoyu Liu; Junqing An; Miao Zhang; Yu Qiu; Ming-Hui Zou
Journal:  Cell Mol Immunol       Date:  2021-11-02       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.